Aleksandrova Y - Search Results

1

N-Alkylation of Anthracycline Antibiotics by Natural Sesquiterpene Lactones as a Way to Obtain Antitumor Agents with Reduced Side Effects.

Neganova M, Semakov A, Aleksandrova Y, Yandulova E, Pukhov S, Anikina L, Klochkov S. Neganova M, et al. Among authors: aleksandrova y. Biomedicines. 2021 May 13;9(5):547. doi: 10.3390/biomedicines9050547. Biomedicines. 2021. PMID: 34068225 Free PMC article.

2

Synthesis and Cytotoxic Activity of Azine Derivatives of 6-Hydroxyxanthanodiene.

Neganova ME, Klochkov SG, Pukhov SA, Afanasieva SV, Aleksandrova YR, Yandulova EY, Avila-Rodriguez MF, Mikhaleva LM, Nikolenko VN, Somasundaram SG, Kirkland CE, Aliev G. Neganova ME, et al. Among authors: aleksandrova yr. Curr Cancer Drug Targets. 2020;20(9):666-674. doi: 10.2174/1568009620999200421200338. Curr Cancer Drug Targets. 2020. PMID: 32316892

3

New Spirocyclic Hydroxamic Acids as Effective Antiproliferative Agents.

Neganova ME, Klochkov SG, Aleksandrova YR, Osipov VN, Avdeev DV, Pukhov SA, Gromyko AV, Aliev G. Neganova ME, et al. Anticancer Agents Med Chem. 2021;21(5):597-610. doi: 10.2174/1871520620666200527132420. Anticancer Agents Med Chem. 2021. PMID: 32459611

4

Histone modifications in epigenetic regulation of cancer: Perspectives and achieved progress.

Neganova ME, Klochkov SG, Aleksandrova YR, Aliev G. Neganova ME, et al. Semin Cancer Biol. 2022 Aug;83:452-471. doi: 10.1016/j.semcancer.2020.07.015. Epub 2020 Aug 16. Semin Cancer Biol. 2022. PMID: 32814115 Review.

5

The Hydroxamic Acids as Potential Anticancer and Neuroprotective Agents.

Neganova ME, Klochkov SG, Aleksandrova YR, Aliev G. Neganova ME, et al. Curr Med Chem. 2021;28(39):8139-8162. doi: 10.2174/0929867328666201218123154. Curr Med Chem. 2021. PMID: 33342403 Review.

6

Novel Multitarget Hydroxamic Acids with a Natural Origin CAP Group against Alzheimer's Disease: Synthesis, Docking and Biological Evaluation.

Neganova M, Aleksandrova Y, Suslov E, Mozhaitsev E, Munkuev A, Tsypyshev D, Chicheva M, Rogachev A, Sukocheva O, Volcho K, Klochkov S. Neganova M, et al. Among authors: aleksandrova y. Pharmaceutics. 2021 Nov 8;13(11):1893. doi: 10.3390/pharmaceutics13111893. Pharmaceutics. 2021. PMID: 34834312 Free PMC article.

7

Therapeutic Influence on Important Targets Associated with Chronic Inflammation and Oxidative Stress in Cancer Treatment.

Neganova M, Liu J, Aleksandrova Y, Klochkov S, Fan R. Neganova M, et al. Among authors: aleksandrova y. Cancers (Basel). 2021 Dec 1;13(23):6062. doi: 10.3390/cancers13236062. Cancers (Basel). 2021. PMID: 34885171 Free PMC article. Review.

8

Perspectives of using microRNA-loaded nanocarriers for epigenetic reprogramming of drug resistant colorectal cancers.

Sukocheva OA, Liu J, Neganova ME, Beeraka NM, Aleksandrova YR, Manogaran P, Grigorevskikh EM, Chubarev VN, Fan R. Sukocheva OA, et al. Semin Cancer Biol. 2022 Nov;86(Pt 2):358-375. doi: 10.1016/j.semcancer.2022.05.012. Epub 2022 May 24. Semin Cancer Biol. 2022. PMID: 35623562 Review.

9

Benefits and limitations of nanomedicine treatment of brain cancers and age-dependent neurodegenerative disorders.

Neganova ME, Aleksandrova YR, Sukocheva OA, Klochkov SG. Neganova ME, et al. Semin Cancer Biol. 2022 Nov;86(Pt 2):805-833. doi: 10.1016/j.semcancer.2022.06.011. Epub 2022 Jun 30. Semin Cancer Biol. 2022. PMID: 35779712 Review.

10

Synthesis and biological testing of 3,5-bis(arylidene)-4-piperidone conjugates with 2,5-dihydro-5H-1,2-oxaphospholenes.

Neganova ME, Aleksandrova YR, Nikolaeva NS, Brel VK. Neganova ME, et al. Bioorg Med Chem Lett. 2022 Oct 15;74:128940. doi: 10.1016/j.bmcl.2022.128940. Epub 2022 Aug 12. Bioorg Med Chem Lett. 2022. PMID: 35964843

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

41 results

Search Page

Filters